about
The primary prevention of birth defects: Multivitamins or folic acid?Risk and benefit of drug use during pregnancy.Evaluation of maternal infusion therapy during pregnancy for fetal developmentUse of inhaled and oral corticosteroids in pregnancy and the risk of malformations or miscarriageNo association of maternal vitamin E intake with higher risk of cardiovascular malformations in children: a population-based case-control studyPopulation-based case-control study of oral ketoconazole treatment for birth outcomes.Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments.Interpretation of controversial teratogenic findings of drugs such as phenobarbital.Birth outcomes of newborns after folic Acid supplementation in pregnant women with early and late pre-eclampsia: a population-based study.Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth.The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology.Microorganisms in the female genital tract during pregnancy: tolerance versus pathogenesis.Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study.Birth outcomes of cases with left-sided obstructive defects of the heart in the function of maternal socio-demographic factors: a population-based case-control study.Association of maternal diseases during pregnancy with the risk of single ventricular septal defects in the offspring--a population-based case-control study.Birth outcomes of cases with isolated atrial septal defect type II--a population-based case-control study.A possible association between acute infectious diarrhoea in pregnant women and congenital abnormalities in their offspring--a population-based case-control study.Acute respiratory infections during pregnancy and congenital abnormalities: a population-based case-control study.Birth outcomes of patients with isolated anorectal malformations: A population-based case-control study.Maternal factors in the origin of infantile hypertrophic pyloric stenosis: A population-based case-control study.Maternal factors in the origin of isolated oesophageal atresia: A population-based case-control study.Association between severe nausea and vomiting in pregnancy and lower rate of preterm births.Maternal demographic and socioeconomic characteristics of live-born infants with isolated ocular congenital abnormalities.A population-based case-control study of oral griseofulvin treatment during pregnancy.The efficacy of antihypertensive treatment in pregnant women with chronic and gestational hypertension: a population-based study.Rate of preterm births in pregnant women with common lower genital tract infection: a population-based study based on the clinical practice.Association between bronchial asthma in pregnancy and shorter gestational age in a population-based study.Association of drug treatments in pregnant women with the risk of external ear congenital abnormalities in their offspring: a population-based case-control study.Isolated atrioventricular canal defects: birth outcomes and risk factors: a population-based Hungarian case-control study, 1980-1996.Distribution of maternal age and birth order groups in cases with unclassified multiple congenital abnormalities according to the number of component abnormalities: a national population-based case-control study.Population-based case-control teratologic study of topical miconazole.Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy.Rate of preterm birth in pregnant women with vitamin E treatment: a population-based study.Birth outcomes of cases with conotruncal defects of heart - a population-based case-control study.Risk factors in the origin of congenital left-ventricular outflow-tract obstruction defects of the heart: a population-based case-control study.Population-based case-control study of mebendazole in pregnant women for birth outcomes.A population-based case-control teratological study of oral nystatin treatment during pregnancy.A population-based case-control study on the effect of bronchial asthma during pregnancy for congenital abnormalities of the offspring.Maternal characteristics and birth outcomes of pregnant women who had offspring with congenital ear abnormalities - a population-based case-control study.Risk of specific congenital abnormalities in offspring of women with diabetes.
P2860
Q24791130-D321E92F-15D1-4E93-B496-A31AA15E982AQ24814975-C2AD58DF-8BB3-4232-B8DB-BB0C1496233FQ24817174-A076C29A-2DF0-4A7F-8247-674752E426DEQ26825323-854F289D-4980-4D3C-B187-560E9EB4E52BQ33949279-43E6295C-DACA-474B-A81C-30A5CC56B230Q34398653-7FBC4B17-0115-43C7-8915-64F9C576E7A0Q34623571-7789503B-1692-4378-AEE6-96713835140DQ35195772-223566BA-CF10-4D23-AEA1-85BF8FC0EEAFQ35202018-0CF52AEB-3091-4982-8D9B-EFED10FB2FE3Q36102625-8ACE9452-FEE1-45DA-A030-7E06A99AD0DAQ37510943-8B453C3F-3D56-4CBF-B92C-59BE90D6D8A6Q38253150-85214341-0BFE-49DE-9A5F-CA3131FD2B71Q39813503-68B59406-7DFF-436A-85A2-2B68F50410B2Q40051235-24DD2B16-6A3E-4B5A-BE66-0502CB8B82C3Q40078233-8ABC36B7-17B0-478E-9C39-50D13AF8468AQ40078716-907F54F4-E2A1-4272-A8B4-047D73658B09Q40367950-7EED841C-D943-46AE-A447-43BC2DBB4955Q40478091-539B8B06-F8E3-40E2-8D29-AB877506C50BQ40640740-29607127-F154-48A0-97E0-EDE30F2F6247Q41333984-C1506B3C-88E4-4FBE-B5C8-45512DBC1A0FQ41701436-38AE5FC1-C1A9-4C06-A557-5634C7FFC8EFQ43418237-0A876913-71E2-44D9-9264-0FCAA11E0687Q43501942-F33498F0-E90E-4C67-9117-882DB975EE79Q43572393-2ED38800-0630-4A9F-924E-4E8E57FDF828Q43648402-538AE52F-1387-4746-97D7-4634E628DB59Q43663591-80716110-790A-4E68-8EA4-7BC8FAF4D6E6Q43752093-C1B8878B-781D-4A75-A503-9F2C1E301C58Q43898078-7A533E72-6E0B-49FF-BDF5-79C875DE6E00Q44408265-ECCA42EE-2FD1-4B7A-9D3F-58D13FEFEDAEQ44771185-3DDB1674-6940-45D9-9ED9-4C30C5F3A9FBQ44791721-C89ED43E-7E01-4677-AE10-CA885B77CE75Q44937870-F7B8B13D-75EE-46E4-BC97-920B0482BC43Q45834847-F33052C8-3D81-4921-A5FA-5565F1289A50Q46379193-2B215667-FAC6-4B8B-BFD6-8C8534C30874Q46404500-81814922-541B-4B21-A050-655F2DA4D838Q46677413-82566086-0305-48A6-A958-38F35D43AD5FQ47266064-9FE7C900-6260-4E14-9A89-2BF3DCED76E4Q47646379-BFF627A0-8325-4FFB-A042-6D18B6E601C1Q51886670-6BB53BA3-3829-4539-B904-BDE95E92C925Q53755458-F7309ADC-0901-4813-A2AC-CC2FC34BB7DE
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Validation studies of drug exposures in pregnant women.
@en
Validation studies of drug exposures in pregnant women.
@nl
type
label
Validation studies of drug exposures in pregnant women.
@en
Validation studies of drug exposures in pregnant women.
@nl
prefLabel
Validation studies of drug exposures in pregnant women.
@en
Validation studies of drug exposures in pregnant women.
@nl
P2093
P356
P1476
Validation studies of drug exposures in pregnant women.
@en
P2093
P304
P356
10.1002/PDS.766
P577
2003-07-01T00:00:00Z